Evidence-Based. Clearly Delivered.
Evidence-Based. Clearly Delivered.
The goal of this atlas is to provide a quick resource that you can easily access on your computer or phone to help assess what is ‘normal’. Before moving on to diagnose what is ‘abnormal’, it is vital to be confident with what ‘normal’ fetal anatomy looks like during the second trimester scan.
While different countries may have different standards for timing of the 2nd trimester ultrasound. Biometry algorithms may likewise be dissimilar. But fetal anatomy is universal.
Aside from the brief summaries and ‘tips’, scroll down and you will find The ObG Project entries related to structures being reviewed, including current guidelines. Tap key words for helpful glossary terms.
Even in the best of hands, structural anomalies can be missed. It is always important to let a patient know that birth defects can occur in 3 to 4% of pregnancies and many, but not all abnormalities, can be detected on ultrasound. Sometimes the problem is simply too small to see, while some defects may not develop until later in the pregnancy.
If ever there is the slightest doubt as to whether an image is ‘normal’, consider referral to a center with expertise in fetal ultrasound to confirm whether there is a structural abnormality, and if so, to make a diagnosis quickly. You can find helpful resources, including where to find a maternal fetal medicine expert (US) and genetic services (US and Canada).
Sina Haeri MD, MHSA, FACOG for providing ‘Key Points’ and highlights.
AIUM Practice Parameter for the Performance of Standard Diagnostic Obstetric Ultrasound
Updated ISUOG Practice Guidelines: fetal cardiac screening
ISUOG: Performance of the routine mid-trimester fetal ultrasound scan
Maternal-Fetal Medicine Specialist Locator-SMFM
Please log in to ObGFirst to access this page
OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Jointly provided by
